Andrew R. Allen - 15 Dec 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC. (TCRR)

Role
Director
Signature
/s/ Margaret Siegel as Attorney-in-Fact
Issuer symbol
TCRR
Transactions as of
15 Dec 2022
Transactions value $
$0
Form type
4
Filing time
19 Dec 2022, 16:24:12 UTC
Previous filing
01 Jul 2022
Next filing
06 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRR Stock Option (Right to Buy) Award $0 +16.8K $0.00 16.8K 15 Dec 2022 Common Stock 16.8K $0.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in twenty-four (24) equal monthly installments thereafter.